These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19000077)

  • 1. A mathematical model of protease-antiprotease homeostasis failure in chronic obstructive pulmonary disease (COPD).
    Cox LA
    Risk Anal; 2009 Apr; 29(4):576-86. PubMed ID: 19000077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of smoking on peripheral blood leukocytes and serum antiproteases.
    Bridges RB; Wyatt RJ; Rehm SR
    Eur J Respir Dis Suppl; 1985; 139():24-33. PubMed ID: 2995105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A causal model of chronic obstructive pulmonary disease (COPD) risk.
    Cox LA
    Risk Anal; 2011 Jan; 31(1):38-62. PubMed ID: 20846171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteases involved in airway inflammation of COPD].
    Kasagi S; Seyama K; Fukuchi Y
    Nihon Rinsho; 2003 Dec; 61(12):2113-8. PubMed ID: 14674319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional significance of apoptosis in chronic obstructive pulmonary disease.
    Park JW; Ryter SW; Choi AM
    COPD; 2007 Dec; 4(4):347-53. PubMed ID: 18027162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease.
    Ziora D; Dworniczak S; Kozielski J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():809-17. PubMed ID: 19218708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cigarette smoking and drugs on respiratory tract proteases and antiproteases.
    Tetley TD; Smith SF; Burton GH; Winning AJ; Cooke NT; Guz A
    Eur J Respir Dis Suppl; 1987; 153():93-102. PubMed ID: 3322871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The genetics of chronic obstructive pulmonary disease].
    Arinir U; Hoffjan S; Knoop H; Schultze-Werninghaus G; Epplen JT; Rohde G
    Pneumologie; 2009 Jan; 63(1):41-8. PubMed ID: 19137504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokines and proteases involved in pathogenesis of COPD].
    Yamaya A; Osanai K
    Nihon Rinsho; 2011 Oct; 69(10):1748-53. PubMed ID: 22073567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of COPD: lessons learned from in vivo animal models.
    Fujita M; Nakanishi Y
    Med Sci Monit; 2007 Feb; 13(2):RA19-24. PubMed ID: 17261992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteases and protease inhibitors of possible clinical relevance in COPD of horses].
    von Fellenberg R
    Tierarztl Prax; 1987; 15(4):399-407. PubMed ID: 3327200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Protease-Antiprotease Imbalance Explain Chronic Obstructive Pulmonary Disease?
    Lomas DA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S130-7. PubMed ID: 27115947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathobiologic mechanisms of chronic obstructive pulmonary disease.
    Tam A; Sin DD
    Med Clin North Am; 2012 Jul; 96(4):681-98. PubMed ID: 22793938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of COPD. Part III. Inflammation in COPD.
    Roth M
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):375-80. PubMed ID: 18371261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD).
    Daheshia M
    Curr Med Res Opin; 2005 Apr; 21(4):587-94. PubMed ID: 15899108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
    Bolton CE; Stone MD; Edwards PH; Duckers JM; Evans WD; Shale DJ
    Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction.
    Chillappagari S; Preuss J; Licht S; Müller C; Mahavadi P; Sarode G; Vogelmeier C; Guenther A; Nahrlich L; Rubin BK; Henke MO
    Respir Res; 2015 Jul; 16(1):85. PubMed ID: 26169056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.